Mukherjee lab studies the role of MUC1 in pancreatic & breast cancer. Novel strategies including targeted therapy with antibody & CAR T cells are explored.
Our article on MUC1-regulated TGF-b signaling has been published in Frontiers in Cell and Developmental Biology!
Full article link: https://t.co/T1S3ep560T
@lab_pinku@BoseMukulika#UNCC#CancerResearch
The Mukherjee lab has recently published the critical role of normal Mucin1 (MUC1) in the host organism on the expansion and immunosuppressive function of myeloid-derived-suppressor cells (MDSCs).
Please see the link to the full text- https://t.co/xCZvbNY1h8
#immunotherapy#MUC1
The Mukherjee Lab has recently published a review in the journal "Vaccines" on the potential of anti-MUC1 antibodies as a targeted therapy for Gastrointestinal Cancers. Congratulations to the authors!
https://t.co/yPrtQ60OJt
We are excited to share our new publication in Critical Reviews in Microbiology! 🤩
In this work, we discuss the role of gamma-delta T cells in immune response against SARS-CoV-2 and potential therapeutic strategies.
Thank you @AliceBertaina@nargeso0
https://t.co/7uDZZ134ck
Congratulations to @priyankagrover from @lab_pinku who will be joining Piper Sandler investment bank as a Biotechnology Equity Research Associate!! She will focus on the drug discovery sector of emerging Biopharma. @UNCC_CLAS @uncc_orcd @UNCCnews https://t.co/GrXLOvMRs2
Thank you @ChancellorGaber for visiting @UNCC_CLAS this week & learning about the local and global impact of our diverse people, academic programs and research - including the cancer research in Associate Dean Pinku Mukherjee's lab. (Photos: Wade Bruton and @GregWeeksCLT)
The Mukherjee lab recently published their work in Theranostics. Congratulations to all the authors!
Preclinical evaluation of an <sup>111</sup>In/<sup>225</sup>Ac theranostic targeting transformed MUC1 for triple negative breast cancer https://t.co/fmrxvzRODF #Theranostics